As of December 2024, Shin Nippon Biomedical Laboratories has a market cap of $444.25M. This makes Shin Nippon Biomedical Laboratories the world's 11963th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $426.24M | -5.24% |
2023 | $449.82M | -24.87% |
2022 | $598.70M | 59.15% |
2021 | $376.17M | 110.37% |
2020 | $178.81M | 6.97% |
2019 | $167.16M | -5.82% |
2018 | $177.49M | 15.72% |
2017 | $153.38M | -1.19% |
2016 | $155.24M | 41.20% |
2015 | $109.94M | -47.53% |
2014 | $209.54M | -40.75% |
2013 | $353.65M | 326.52% |
2012 | $82.92M | 59.69% |
2011 | $51.92M | -49.22% |
2010 | $102.26M | -29.82% |
2009 | $145.70M | -22.32% |
2008 | $187.56M | -58.43% |
2007 | $451.14M | -20.61% |
2006 | $568.23M | 9.94% |
2005 | $516.84M | 390.82% |
2004 | $105.30M | - |